Immune Checkpoint Inhibitor Metastatic NSCLC: Combination Strategies

Edward B. Garon, MD, MS, provides his expert perspective on immune checkpoint inhibition in metastatic non-small cell lung cancer (mNSCLC) and evaluates the currently available immunotherapy combinations.